Recommended Medications and Treatments for Constipation
For most patients with constipation, a stepwise approach starting with osmotic laxatives such as polyethylene glycol (PEG) or stimulant laxatives is recommended as first-line pharmacological therapy, with fiber supplementation as an adjunctive treatment. 1
First-Line Treatments
Non-Pharmacological Approaches
- Ensure adequate hydration and increase fluid intake 1
- Increase physical activity and mobility within patient limits 1
- Optimize toileting position (using a footstool can help) and ensure privacy 1
- Establish regular toileting habits, attempting defecation 30 minutes after meals 1
- Consider abdominal massage, particularly for patients with neurogenic problems 1
Fiber Supplementation
- Recommended initial dose: 14g/1,000 kcal intake per day 1
- Psyllium appears to be the most effective fiber supplement compared to other types 1, 2
- Ensure adequate hydration when increasing fiber intake 1
- Common side effects include bloating and abdominal discomfort 1
- Not recommended for opioid-induced constipation 1
Pharmacological Treatments
Osmotic Laxatives (First-Line)
- Polyethylene glycol (PEG): 17g daily; no clear maximum dose; $10-$45 monthly 1
- Lactulose: 15g daily; no clear maximum dose; <$50 monthly 1
- Magnesium oxide: 400-500mg daily; no clear maximum dose; <$50 monthly 1
- Use with caution in patients with renal insufficiency 1
Stimulant Laxatives (First-Line)
- Bisacodyl: 5mg daily initially; maximum 10mg daily; <$50 monthly 1
- Senna: 8.6-17.2mg daily; no clear maximum dose; <$50 monthly 1
Second-Line Treatments (Prescription)
Intestinal Secretagogues
- Lubiprostone: 24μg twice daily; $374 monthly 1
- Linaclotide: 72-145μg daily for chronic idiopathic constipation; maximum 290μg daily; $523 monthly 1, 3
- Plecanatide: 3mg daily; $526 monthly 1
- Diarrhea may occur in some patients 1
- Prucalopride: 1-2mg daily; $563 monthly 1
Special Considerations
Opioid-Induced Constipation (OIC)
- All patients receiving opioid analgesics should be prescribed a concomitant laxative unless contraindicated 1
- Osmotic or stimulant laxatives are generally preferred 1
- For unresolved OIC, consider peripherally acting μ-opioid receptor antagonists (PAMORAs) such as methylnaltrexone (0.15 mg/kg subcutaneously) 1
- Bulk laxatives such as psyllium are not recommended for OIC 1
Fecal Impaction
- Digital disimpaction followed by maintenance bowel regimen is recommended 1
- Suppositories and enemas are preferred first-line therapy when digital rectal examination identifies a full rectum or fecal impaction 1
Elderly Patients
- Ensure access to toilets, especially for those with decreased mobility 1
- Provide dietetic support 1
- Optimize toileting habits (attempt defecation twice daily, 30 minutes after meals) 1
- Polyethylene glycol (17g/day) offers an efficacious and tolerable solution with good safety profile 1
- Avoid liquid paraffin for bed-bound patients and those with swallowing disorders due to risk of aspiration 1
Treatment Algorithm
- Start with non-pharmacological approaches and fiber supplementation (if not OIC) 1
- If inadequate response, add osmotic laxative (PEG preferred) 1, 4
- If still inadequate, add or switch to stimulant laxative 1
- For persistent symptoms, consider prescription medications (secretagogues) 1
- For OIC, use osmotic or stimulant laxatives first, then consider PAMORAs if refractory 1
Common Pitfalls
- Not all fiber supplements are equally effective; psyllium has better evidence than other types 1, 2
- Inadequate fluid intake when increasing fiber can worsen constipation 1
- Using bulk-forming laxatives in opioid-induced constipation 1
- Failure to recognize and treat fecal impaction before starting a maintenance regimen 1
- Not adjusting laxative doses when increasing opioid doses 1
- Using magnesium salts in patients with renal impairment 1